Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Pioglitazone Effects on Fetuin-A and OPG in T2DM
NCT02027103Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2012
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Metformin with Pioglitazone (2 arms). Primary endpoints: Serum concentrations of fetuin-A at 12 weeks and Serum concentrations of osteoprotegerin at 12 weeks. Started Jan 2012; status: completed.
02
Drugs
metforminpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02027103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027103.